Cited by 892Cancer Cells and MetastasisAcute Lymphoblastic Leukemia researchDrug Transport and Resistance Mechanisms

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Environment-mediated drug resistance: a major contributor to minimal residual disease

Meads, Mark B., Gatenby, Robert A., Dalton, William S.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Environment-mediated drug resistance is a form of de novo drug resistance that protects tumour cells from the initial effects of diverse therapies. Surviving foci of residual disease can then develop complex and permanent acquired resistance in response to the selective pressure of therapy. Recent evidence indicates that environment-mediated drug resistance arises from an adaptive, reciprocal signalling dialogue between tumour cells and the surrounding microenvironment. We propose that new therapeutic strategies targeting this interaction should be applied during initial treatment to prevent the emergence of acquired resistance.

Integrity signals

Registry

Crossref · 10.1038/nrc2714

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Treatment of Acute Lymphoblastic Leukemia
Pui, C., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 2,012
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Stromal Gene Signatures in Large-B-Cell Lymphomas
Lenz, G., Wright, G. W., Davé, S. S., Xiao, W., Powell, J. I., Zhao, H., Xu, W., Tan, B. T., Goldschmidt, N., Iqbal, J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802885 · Cited by 1,847
Stimulation of Bone Formation in Vitro and in Rodents by Statins
Mundy, G. R., Garrett, R., Harris, S., Chan, J., Chen, D., Rossini, G., Boyce, B. F., Zhao, M., & Gutierrez, G. (1999) · Science · doi:10.1126/science.286.5446.1946 · Cited by 1,776
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Ömeroğlu, G., Meterissian, S. H., Ömeroğlu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,707
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Self-citation
Reversion of the Malignant Phenotype of Human Breast Cells in Three-Dimensional Culture and In Vivo by Integrin Blocking Antibodies
Weaver, V. M., Petersen, O. W., Wang, F., Larabell, C. A., Briand, P., Damsky, C., & Bissell, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.1.231 · Cited by 1,483
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,380
DQIS — Distributed Quorum-Based Independent Immune Surveillance: A Theoretical Framework for Byzantine Fault Tolerance for Multi-Channel Immune Surveillance
DQIS Research Group (2026) · PubMed · doi:10.5281/zenodo.21937949 · Cited by 1,333

Flagged first, then by citations

Show all 109 references

Research works printed but not linked: 1

Goldie, J. H. & Coldman, A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 63, 1727–1733 (1979).

Sorted by citations

Items 801–892 of 892

SUBMISSION OF A REVIEW ARTICLE FOR EVALUATION.
B.Tech (Electronics and Telecommunication), S. N., Padhi, N., Patil, S., & Member, I. (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/1660
Computational biology approaches in drug repruposing and gene essentiality screening
Philips, S. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2j30f
Characterisation of Resistance to Everolimus in Acute Lymphoblastic Leukemia
Basnett, J. (2016) · The Sydney eScholarship Repository (The University of Sydney)
The role of fibroblasts in cancer progression, therapy resistance and field cancerization
Chan, J. S. K. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72335
FOXP3-positive regulatory T cells are correlated with improved survival in diffuse large B-cell non-Hodgkin lymphoma
Mohamed, G., Abulkheir, I. L. H., & Mourad, M. (2017) · Egyptian Journal of Pathology · doi:10.1097/01.xej.0000516725.09698.d3
Microenvironmental Regulation of Tumor Resistance to Anti-IGF-1R Monoclonal Antibody
이지선 (2017) · Seoul National University Open Repository (Seoul National University)
Regulation of lysophosphatidate-induced mechanisms of chemo-resistance
Venkatraman, G. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3bn9x79k
The Role of STAT3 in the Pathogenesis of Chronic Lymphocytic Leukaemia
Brophy, S. (2018) · Trinity's Access to Research Output (TARA) (Trinity College Dublin)
Avaliação da influência da expressão de STAT1 na resposta ao tratamento quimioterápico no cancêr de ovário seroso de alto grau
Josahkian, J. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-21072016-151516
Bio-nano: Theranostic at Cellular Level
Kluenker, M., Kurch, S., Tahir, M. N., & Tremel, W. (2018) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-94174-5_3 · Cited by 1
Exploring the Regulatory Mechanism of the Notch Ligand Receptor Jagged1 Via the Aryl Hydrocarbon Receptor in Breast Cancer
Piwarski, S. A. (2018)
Phenotypic evolution of cancer cells: structural requirements for survival
Atrian, F., & Lelièvre, S. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00002-8
Interaction of cancer cells with mesenchymal stem cells: implications in metastatic progression
Khurana, S., & Bhattacharyya, S. (2020) · Journal of the Indian Institute of Science · doi:10.1007/s41745-020-00182-5
Acquired deficiency of the peroxisomal enzyme enoyl-CoA hydratase/3-hydroxyacyl CoA dehydrogenase is a metabolic vulnerability in hepatoblastomaPreprint
Wang, H., Chen, X., Schwalbe, M., Gorka, J. E., Mandel, J. A., Wang, J., Lu, J. L., Goetzman, E. S., Dobrowolski, S. F., & Prochownik, E. V. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.24.265421
Lymphoid Cancers Thwart Marrow Response to Therapeutic Antibodies, But Chemotherapy Triggers “ASAP” to Save the Day
Becker, P. S. (2014) · The Hematologist · doi:10.1182/hem.v11.4.2951
Treatment with 188Re Reduces Cancerous Phenotype in Liver Cancer CellsPreprint
Asadian, S., Piryaei, A., Gheibi, N., Kalantari, B. A., Davarpanah, M. R., Saberi, S., Azad, M., Капустина, В., Nejad, S. M., Mohamadi, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-398524/v1
Ovarian Cancer: Towards Personalizing Ovarian Cancer Treatments Using Patient-Derived Organoids
Volpari, T., Hebner, J., Aiyar, R. S., & Martin, L. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00080-3
Drugs Resistance Management
Bashir, N., Ashraf, S., Rashid, N., Naqvi, S. T. R., Majeed, S., Murtaza, G., Ashiq, M. N., & Haq, M. N. U. (2021) · Springer eBooks · doi:10.1007/978-3-030-76320-6_21
Development of different organ derived decellularized tissue gels that support in vitro tumor cell behavior in a tumor type-specific manner
Ono, T., Noguchi, R., Yoshimatsu, Y., Sin, Y., Kojima, N., & Kondo, T. (2021) · Journal of Electrophoresis · doi:10.2198/jelectroph.65.33
Endothelial Cells Immune-Related Genes Risk Signature Correlated With Tumor Immune Microenvironment Predicts Therapeutic Response and Prognosis in GlioblastomaPreprint
Xie, Q., Zhang, Y., Wu, H., Wang, H., & Liu, F. (2021) · Research Square · doi:10.21203/rs.3.rs-1053908/v1
In the Hot Box and on the Tube: Witnesses' Interests in Televised Trials
Horth-Neubert, S. R. (1997) · FLASH - Fordham Law Archive of Scholarship & History (Fordham University)
Systems Biology and Genomics
Hassan, S. N., Heiser, L. M., & Gray, J. W. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm019
Leukemias
Ginaldi, L., & Martinis, M. D. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-615-9_6
Cancer Stem Cells
Balla, M. M. S., Kusumbe, A. P., Vemuganti, G. K., & Bapat, S. A. (2013) · Springer eBooks · doi:10.1007/978-94-007-5690-8_15
Chirurgische Onkologie
Flebbe, H., & Grade, M. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-24706-4.00027-8
Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer
Ata, R., & Antonescu, C. N. (2021) · doi:10.32920/14639496
Breast Cancer Drug Resistance
Addison, C., & Cabrita, M. A. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_6674
Drug Resistance
Wang, B. (2014) · Springer eBooks · doi:10.1007/978-3-662-46875-3_1739
Breast Cancer Drug Resistance
Addison, C., & Cabrita, M. A. (2014) · Springer eBooks · doi:10.1007/978-3-642-27841-9_6674-2
ACUTE LEUKEMIAS XV
Christopeit, M., Tischer, J., Bornhäuser, M., Uharek, L., Pfrepper, C., Behre, G., Niederwieser, D. W., Kroger, N., Rösler, W., Klein, S., et al. (2015) · Annals of Hematology · doi:10.1007/s00277-014-2297-4
Drug Resistance
Wang, B. (2014) · Springer eBooks · doi:10.1007/978-3-642-27841-9_1739-7
Faculty Opinions recommendation of Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.
Zhao, H., & Zhu, X. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717996667.793474070
Breast Cancer Drug Resistance
Addison, C., & Cabrita, M. A. (2017) · Springer eBooks · doi:10.1007/978-3-662-46875-3_6674
Glioma and Exosome
(2021) · Letters in Applied NanoBioScience · doi:10.33263/lianbs111.32323248
TGF-β in patients with hematologic malignancies
Nanava, N., Metreveli, S., Giorgobiani, G., Chikovani, T., & Janikashvili, N. (2022) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2022.04.05.04
CD4+CD39+ cells in patients with hematologic malignancies
Nanava, N., Metreveli, S., Giorgobiani, G., Chikovani, T., & Janikashvili, N. (2022) · GEORGIAN SCIENTISTS · doi:10.52340/gs.2022.04.05.03
Systems Biology and Genomics
Hassan, S. N., Gray, J. W., & Heiser, L. M. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm019.pub2
Understanding of ‘Networks’ In Vitro and/or In Vivo
Schoof, E. M., Ferkinghoff‐Borg, J., & Linding, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.40027-1
Delay tumor progression with the introduction of engineered impactive cellsPreprint
Hong, D., Shuiping, L., Ma, J., Mu, L., Wu, W., Hu, Y., Wang, Y., Guo, X., Cai, J.-J., Wang, X., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2641539/v1
Exposure to Moringa oleifera microRNAs induces proteomic changes linked to tumorigenesis and epithelial-mesenchymal transition in HeLa cells
Potestà, M., Gismondi, A., DˈAmbrosio, C., Roglia, V., Camoni, L., Marra, M., Canini, A., Arena, S., Scaloni, A., Montesano, C., et al. (2023) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2023.100097
Data from A Functional Receptor for B-Cell–Activating Factor Is Expressed on Human Acute Lymphoblastic Leukemias
Parameswaran, R., Müschen, M., Kim, Y., Groffen, J., & Heisterkamp, N. (2023) · doi:10.1158/0008-5472.c.6499989.v1
Data from The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
Harney, A. S., Karagiannis, G. S., Pignatelli, J., Smith, B. D., Kadioglu, E., Wise, S., Hood, M. M., Kaufman, M. D., Leary, C. B., Lu, W.-P., et al. (2023) · doi:10.1158/1535-7163.c.6538714.v1
Dynamics of Drug Resistance
Jackson, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-32573-1_6
A 3D microtumour system that faithfully represents ovarian cancer minimal residual diseasePreprint
Yang, X., Artibani, M., Jin, Y., Aggarwal, A., Zhang, Y., Muñoz-Galván, S., Mikhailova, E., Rai, L. J., Mukherjee, N., Kumar, R. K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.15.549155
Expression of the WNT Family Genes in Multiple Myeloma Patients with Different Chemotherapy Response
Enukashvili, N. I., Белик, Л. А., Kostroma, I. I., Семенова, Н. Ю., Балашова, В. А., Барам, Д. В., Грицаев, С. В., Бессмельцев, С. С., Sidorkevich, S. V., & Мартынкевич, И. С. (2023) · Clinical oncohematology · doi:10.21320/2500-2139-2023-16-3-294-302
Single-Cell Transcriptomics of Glioblastoma Reveals Pericytes Contributing to Blood–Brain Tumor Barrier and Tumor ProgressionPreprint
Li, Y., Wu, C., Long, X., Wang, X., Gao, W., Deng, K., Xie, B., Zhang, S., Wu, M., & Liu, Q. (2023) · Research Square · doi:10.21203/rs.3.rs-3561475/v1
Tumor Inflammatory Microenvironment in Lung Cancer: Heterogeneity and Implications
Bhatia, A., Sobti, R. C., & Sharma, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_20
Cell-type dependent effect of 3D collagen matrix on cancer cell resistance to suboptimal conditions: the case of serum deprivation, glucose starvation, and hypoxia
Sencha, L. M., Karpova, M. A., Dobrynina, O. E., & Balalaeva, I. V. (2025) · Tissue and Cell · doi:10.1016/j.tice.2024.102719
Stroma-driven horizontal transfer of TCA proteins mediates metabolic plasticity and imatinib resistance in leukemiaPreprint
Piwocka, K., Chrościcki, P., Kasak, N., Dymkowska, D., Turos-Korgul, L., Cysewski, D., Chumak, V., Stępnik, D., Kusio-Kobiałka, M., Lebiedzińska, M., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6120387/v1
A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy
Liu, Z., Mao, Y., Wang, S., Zheng, H., Yang, K., Yang, L., & Huang, P. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1566227
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer
Pfeiffer, A., Leo, L. D., Bechmann, M. B., Nawabi, M., Ambjørner, S. E. B., Ardeshir-Larijani, D., Colstrup, L. T., Borchert, S. V., Saaby, L., Brodin, B., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083790
Expression of WNT Family Genes in Mesenchymal Stromal Cells of the Hematopoietic Niche in Patients with Different Responses to Multiple Myeloma Treatment
Belik, L. A., Enukashvily, N. I., Semenova, N. Y., Ostromyshenskii, D. I., Motyko, E., Kirienko, A., Kustova, D. V., Бессмельцев, С. С., Sidorkevich, S. V., & Мартынкевич, И. С. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136236
Challenges and opportunities in nanodots research for cancer
Jani, S. N., Katariya, H. B., & Prajapati, B. G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27511-1.00007-8
Stem Cells and Leukemia
Giambra, V., & Jenkins, C. R. (2011) · Springer eBooks · doi:10.1007/978-94-007-2801-1_13
Development of Resistance in Tumor for the Available Conventional Therapies
Sharma, P., Sharma, J., Nayak, B., Tiwari, S., & Kumar, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-5989-3_8
Chemotactic Feedback Controls Patterning in Hybrid Tumor–Stroma Model
Yu, J., Wang, L. S., Liu, Z., & Liu, J. (2026) · Bulletin of Mathematical Biology · doi:10.1007/s11538-026-01745-w
Cancer, collapse, and the politics of somatic evolution
Salzet, M. (2026) · Evolution Medicine and Public Health · doi:10.1093/emph/eoag004
Role of stroma and Wound Healing in carcinoma response to ionizing radiation
Arshad, A. (2014) · theses.fr (ABES) · doi:10.70675/64b07d78z5f57z479ezb5e7za4825a30617d
Fonctions oncogéniques de STAT5 : rôle dans la régulation du métabolisme oxydatif
Bourgeais, J. (2015) · theses.fr (ABES) · doi:10.70675/642a7bdcz3eb5z47fcza4fez4dd048c937e2
La Neuropiline-1, un nouveau biomarqueur de résistance thérapeutique du cancer de la prostate
Blanc, C. (2016) · theses.fr (ABES) · doi:10.70675/b45322c5z1cbdz42c4zba0azdb401927d53c
Rôle de la kinase Akt dans la chimiorésistance : Régulation de l’équilibre Apoptose-Sénescence
Vétillard, A. (2015) · theses.fr (ABES) · doi:10.70675/d0db61dazb197z42dczbb98z6f0276f570b6
Evaluation des modifications transcriptionnelles, phénotypiques et fonctionnelles des cellules souches mésenchymateuses dans les leucémies aiguës myéloblastiques de novo
Desbourdes, L. M. (2015) · theses.fr (ABES) · doi:10.70675/625718ecze05fz451fzb8baz7c7ee0ba1b6e
Effets de l’hypoxie sur la régulation de l’expression et la fonction de la tétraspanine CD9 dans les leucémies aiguës lymphoblastiques de l’enfant
Rouger, J. (2018) · theses.fr (ABES) · doi:10.70675/89798005zb9a8z4f2ezbed9z033835479236
Modèles 3D de mélanome métastatique pour l’évaluation in vitro de l’efficacité de molécules de thérapies ciblées
Morales, D. (2019) · theses.fr (ABES) · doi:10.70675/c9adb7daze0a4z4783z8800z165e6ca33a5b
Caractérisation de molécules issues de microorganismes associés aux organismes marins, capables d'agir sur les cellules métastatiques du cancer du sein
Dezaire, A. (2018) · theses.fr (ABES) · doi:10.70675/370bd4faz60f7z4872z8de8z81868f186216
Nanophysical and pharmacological approaches to modulate tumor stiffness, extracellular matrix organization and immune response of solid tumors
Nicolás‐Boluda, A. (2019) · theses.fr (ABES) · doi:10.70675/48189727z97c1z43efzbecdz2649f70acac8
Modélisation du microenvironnement tumoral : impact du collagène de type I sur la migration de la cellule tumorale et sur sa réponse à la chimiothérapie
Said, G. (2012) · doi:10.70675/98ec2911zc8cbz4c69z8028z1ae35ec0711c
Régulation de la prolifération des leucémies aiguës lymphocytaires de type B (LAL-B) par le microenvironnement de la moëlle osseuse
Pelletier, J. (2019) · theses.fr (ABES) · doi:10.70675/4adb151dzc474z4467z8a3ez0e929ea88d07
Influence fonctionnelle de l’IMC, de la densité mammaire et du statut ménopausique sur le dialogue entre adipocytes et cellules tumorales mammaires
Zaoui, M. (2018) · theses.fr (ABES) · doi:10.70675/7e124db9z9e85z4d81z906fz646d6224b036
Implication des enzymes de déubiquitination associés au protéasome dans la pathogénie du mélanome
Didier, R. (2018) · theses.fr (ABES) · doi:10.70675/bffe9068z42e1z4f81za32az51df73795ffb
Destruction du microenvironnement tumoral par application de forces mécaniques exercées par des nanoparticules magnétiques
Lopez, S. (2019) · theses.fr (ABES) · doi:10.70675/8b55b975z74ffz4dafz9253z88f55b60aae1
Implication des récepteurs à domaine discoïdine dans la résistance à la thérapie ciblée au cours du mélanome
Sala, M. (2019) · theses.fr (ABES) · doi:10.70675/b13821b9zaa4bz4176zbcd4z3c42b2e64522
Étude des propriétés contractiles des fibroblastes du ganglion lymphatique au cours de la mise en place de la niche pré-métastatique du mélanome
Rovera, C. (2020) · theses.fr (ABES) · doi:10.70675/af78d3ecz2f22z4fe3zaafaz822245a1f598
Etude in vivo de la chimiorésistance dans les leucémies aigues myéloïdes humaines
Aroua, N. (2018) · theses.fr (ABES) · doi:10.70675/87716ea3z1f4dz4a62zb041z59f2afc4c3e9
Etude de l’influence du TGF-β sur les sous-populations de fibroblastes associés au cancer et leur implication pronostique dans les cancers du pancréas
Vienot, A. (2021) · theses.fr (ABES) · doi:10.70675/25d883b4z5eadz4f1bz93f0zcfa886c08e78
Identifier et exploiter de nouvelles vulnérabilités à potentiel thérapeutique dans les leucémies aiguës myéloïdes
Vaganay, C. (2023) · theses.fr (ABES) · doi:10.70675/6370db0dz7cfdz48bfz86e0zc6c293bbe5a4
The pro-fibrotic miR-143/145 cluster promotes mesenchymal phenotypic plasticity associated with resistance to targeted therapies in melanoma
Diazzi, S. (2021) · theses.fr (ABES) · doi:10.70675/d6b2929ezc1c9z4870z8243zec5abc38de89
Rôle de l'enzyme LOXL2 dans le comportement pro-invasif des cellules de mélanome et le remodelage matriciel du stroma tumoral
Carminati, A. (2023) · theses.fr (ABES) · doi:10.70675/03ed9427zb86bz4a59z98f6zc12195d192f7
Direct interaction between cancer cells and fibroblasts promotes early chemoresistance to standard-of-care drug therapy in small cell lung cancer (SCLC)Preprint
Dhungel, N., Latimer, B., Custis, D., & Dragoi, A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.27.721078
BCMA‐Engineered Dendritic Cell‐Derived Exosomes as Bi‐Functional Therapeutics Orchestrating Cytokine Sequestration and Immune Activation for Multiple Myeloma
Zeng, Y., He, C., He, Z., Chen, H., Cheng, F., & Zheng, Y. (2026) · Advanced Science · doi:10.1002/advs.75686 · Cited by 2
Quantitative cancer-immunity cycle modeling: A roadmap from complex dynamics to AI-decoded precision medicine
Li, C., & Lei, J. (2026) · Discrete and Continuous Dynamical Systems - I Intelligence · doi:10.3934/dcdsi.p260201
New insights in tumor-on-a-chip models for studying cancer drug resistance
Wang, Y., Shi, L., Li, J., Zhang, X., Ren, J., Jia, Q., Lv, L., Yang, L., Zhang, Z., Yang, J., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156562
Exosome and extracellular vesicle-based therapeutics to overcome cancer chemoresistance
Seth, P., & Sharma, P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45717-3.00011-8
Depleting S100A4 in Cancer-Associated Fibroblasts Reverses Cisplatin Resistance in Esophageal Cancer
Yu, H., Xu, M., Chen, R., Miao, L., Lü, Z., Lin, Y., Liu, Y., Zheng, W., Ji, T., & Yang, B. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.6c00573
Metastasis as a breakdown of the multicellular social contract
Lagache, L., & Salzet, M. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10352-z
Perspective Chapter: Molecular Determinants of Therapeutic Response in Preclinical Animal Models – From Mechanistic Insights to Translational Precision Medicine
Al-Amri, I. S., Farhadi, S., AlKindi, A. Y., & Al-Rajhi, W. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1016349
Applications in Modern Research
Badal, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-28873-8_6
Cell plasticity in cancer and therapy resistance
Seo, Y., Jang, J., & Park, J. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01869-y · Cited by 1
Resistance in the edges: a relational framework for treatment resistance in genitourinary cancers
Lacerda, D. S., Mastelari, R. B., & Collares, T. V. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1974982
Role of tumor microenvironment in breast cancer development
Mondal, D., Devi, P., Sharma, S., Porel, P., & Debnath, B. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-49074-3.00024-8
Role of stromal fibroblasts in prostate carcinoma progression and metabolic reprogramming of cancer cells
Marini, A. (2014) · UnissResearch (Università degli Studi di Sassari)
Implications of Glioblastoma Stem Cells in Chemoresistance
Kahn, S. A., Torrado, E., Brites, D. M. T. O., & Moura‐Neto, V. (2013) · Springer eBooks · doi:10.1007/978-94-007-6211-4_16

Authors: Meads, M. B., Gatenby, R. A., & Dalton, W. S.
Affiliations: Moffitt Cancer Center (US)
Corresponding author: Dalton, William S.
ORCID: Meads, Mark B.
Gatenby, Robert A.
Dalton, William S.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-08-20
Volume: 9
Issue: 9
Pages: 665-674
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2714
OpenAlex: W2066616821
Cited by: 892
References: 109
Citations by year: 2026: 33 · 2025: 44 · 2024: 35 · 2023: 55 · 2022: 54 · 2021: 74 · 2020: 65 · 2019: 58 · 2018: 56 · 2017: 52 · 2016: 68 · 2015: 61 · 2014: 64 · 2013: 51 · 2012: 52
FWCI: 3.53
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Health Sciences › Medicine › Hematology › Acute Lymphoblastic Leukemia research
Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords: tumor microenvironment, minimal residual disease, recurrence, acquired drug resistance, stromal factors, adjuvant therapy, cancer therapy resistance
MeSH terms: Humans, Neoplasms, Signal Transduction, Stromal Cells, Neoplasm, Residual, Drug Resistance, Neoplasm

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Environment-mediated drug resistance: a major contributor to minimal residual disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks